MedPath

PURINOMIA BIOTECH, INC.

PURINOMIA BIOTECH, INC. logo
🇺🇸United States
Ownership
Private
Established
2017-01-01
Employees
11
Market Cap
-
Website
http://purinomia.com

Safety of PUR001 Monotherapy in Patients With Advanced Solid Tumors

Phase 1
Recruiting
Conditions
Advanced Solid Tumors
Interventions
First Posted Date
2022-02-10
Last Posted Date
2023-01-20
Lead Sponsor
Purinomia Biotech, Inc.
Target Recruit Count
23
Registration Number
NCT05234853
Locations
🇺🇸

The University of Texas MD Anderson Cancer Center, Houston, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath